pubmed-article:9143219 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9143219 | lifeskim:mentions | umls-concept:C0175677 | lld:lifeskim |
pubmed-article:9143219 | lifeskim:mentions | umls-concept:C0025936 | lld:lifeskim |
pubmed-article:9143219 | lifeskim:mentions | umls-concept:C0228174 | lld:lifeskim |
pubmed-article:9143219 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
pubmed-article:9143219 | lifeskim:mentions | umls-concept:C0020746 | lld:lifeskim |
pubmed-article:9143219 | lifeskim:mentions | umls-concept:C0475224 | lld:lifeskim |
pubmed-article:9143219 | lifeskim:mentions | umls-concept:C1366479 | lld:lifeskim |
pubmed-article:9143219 | lifeskim:mentions | umls-concept:C0596988 | lld:lifeskim |
pubmed-article:9143219 | lifeskim:mentions | umls-concept:C0205234 | lld:lifeskim |
pubmed-article:9143219 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
pubmed-article:9143219 | lifeskim:mentions | umls-concept:C0599946 | lld:lifeskim |
pubmed-article:9143219 | lifeskim:mentions | umls-concept:C0280697 | lld:lifeskim |
pubmed-article:9143219 | lifeskim:mentions | umls-concept:C0205374 | lld:lifeskim |
pubmed-article:9143219 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:9143219 | pubmed:dateCreated | 1997-6-4 | lld:pubmed |
pubmed-article:9143219 | pubmed:abstractText | We used transgenic mice expressing a dominant negative mutation of interleukin-1 beta converting enzyme (ICE) (C285G) in a model of transient focal ischemia in order to investigate the role of ICE in ischemic brain damage. Transgenic mutant ICE mice (n = 11) and wild-type littermates (n = 9) were subjected to 3 h of middle cerebral artery occlusion followed by 24 h of reperfusion. Cerebral infarcts and brain swelling were reduced by 44% and 46%, respectively. Neurological deficits were also significantly reduced. Regional CBF, blood pressure, core temperature, and heart rate did not differ between groups when measured for up to 1 h after reperfusion. Increases in immunoreactive IL-1 beta levels, observed in ischemic wild-type brain at 30 min after reperfusion, were 77% lower in the mutant strain, indicating that proIL-1 beta cleavage is inhibited in the mutants. DNA fragmentation was reduced in the mutants 6 and 24 h after reperfusion. Hence, endogenous expression of an ICE inhibitor confers resistance to cerebral ischemia and brain swelling. Our results indicate that downregulation of ICE expression might provide a useful therapeutic target in cerebral ischemia. | lld:pubmed |
pubmed-article:9143219 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9143219 | pubmed:language | eng | lld:pubmed |
pubmed-article:9143219 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9143219 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9143219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9143219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9143219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9143219 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9143219 | pubmed:month | Apr | lld:pubmed |
pubmed-article:9143219 | pubmed:issn | 0271-678X | lld:pubmed |
pubmed-article:9143219 | pubmed:author | pubmed-author:FinkKK | lld:pubmed |
pubmed-article:9143219 | pubmed:author | pubmed-author:EndresMM | lld:pubmed |
pubmed-article:9143219 | pubmed:author | pubmed-author:MoskowitzM... | lld:pubmed |
pubmed-article:9143219 | pubmed:author | pubmed-author:HaraHH | lld:pubmed |
pubmed-article:9143219 | pubmed:author | pubmed-author:YuanJJ | lld:pubmed |
pubmed-article:9143219 | pubmed:author | pubmed-author:FriedlanderR... | lld:pubmed |
pubmed-article:9143219 | pubmed:author | pubmed-author:GagliardiniVV | lld:pubmed |
pubmed-article:9143219 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9143219 | pubmed:volume | 17 | lld:pubmed |
pubmed-article:9143219 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9143219 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9143219 | pubmed:pagination | 370-5 | lld:pubmed |
pubmed-article:9143219 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:9143219 | pubmed:meshHeading | pubmed-meshheading:9143219-... | lld:pubmed |
pubmed-article:9143219 | pubmed:meshHeading | pubmed-meshheading:9143219-... | lld:pubmed |
pubmed-article:9143219 | pubmed:meshHeading | pubmed-meshheading:9143219-... | lld:pubmed |
pubmed-article:9143219 | pubmed:meshHeading | pubmed-meshheading:9143219-... | lld:pubmed |
pubmed-article:9143219 | pubmed:meshHeading | pubmed-meshheading:9143219-... | lld:pubmed |
pubmed-article:9143219 | pubmed:meshHeading | pubmed-meshheading:9143219-... | lld:pubmed |
pubmed-article:9143219 | pubmed:meshHeading | pubmed-meshheading:9143219-... | lld:pubmed |
pubmed-article:9143219 | pubmed:meshHeading | pubmed-meshheading:9143219-... | lld:pubmed |
pubmed-article:9143219 | pubmed:meshHeading | pubmed-meshheading:9143219-... | lld:pubmed |
pubmed-article:9143219 | pubmed:meshHeading | pubmed-meshheading:9143219-... | lld:pubmed |
pubmed-article:9143219 | pubmed:meshHeading | pubmed-meshheading:9143219-... | lld:pubmed |
pubmed-article:9143219 | pubmed:meshHeading | pubmed-meshheading:9143219-... | lld:pubmed |
pubmed-article:9143219 | pubmed:meshHeading | pubmed-meshheading:9143219-... | lld:pubmed |
pubmed-article:9143219 | pubmed:meshHeading | pubmed-meshheading:9143219-... | lld:pubmed |
pubmed-article:9143219 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9143219 | pubmed:articleTitle | Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein. | lld:pubmed |
pubmed-article:9143219 | pubmed:affiliation | Stroke and Neurovascular Regulation, Neurosurgical Service, Massachusetts General Hospital, Harvard Medical School, Charlestown 02129, USA. | lld:pubmed |
pubmed-article:9143219 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9143219 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:9143219 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9143219 | lld:pubmed |